The HDL-transporting scavenger receptor B1 promotes viral infection through endolysosomal acidification
Virus infections pose a continuous threat to human health and can result in millions of deaths per year. SARS-CoV-2 infection has been linked to the high-affinity high-density lipoprotein (HDL) receptor scavenger receptor class B, type 1 (SR-B1). Mechanisms by which SR-B1 supports SARS-CoV-2 infection and replication, as well as the breadth of viruses that exploit this receptor, are incompletely defined. In evaluating the role of SR-B1 in the biology of infection with SARS-CoV-2, influenza A virus, and vesicular stomatitis virus, we show that SR-B1 chemical inhibition or knockout adversely affects infection for these viruses. Inhibiting SR-B1 results in lack of acidification in the endolysosomal compartment and entrapment of SARS-CoV-2 in endosomal-lysosomal vesicles. These findings together indicate that SR-B1, and possibly HDL, is critical for successful SARS-CoV-2 trafficking through a pH-dependent vesicular entry pathway. Our work provides insights into how SR-B1 can impact viral infection in human lung cells.
Authors
- Jill McConnell
- William M. McDougall
- Manish Kandpal (ORCID: https://orcid.org/0000-0001-7352-0849)
- Neal Silverman (ORCID: https://orcid.org/0000-0002-4259-456X)
- Sun-Young Lim
- Evan S. Bradley (ORCID: https://orcid.org/0000-0001-7704-6371)
- Pyae Phyo Kyawe (ORCID: https://orcid.org/0000-0002-8259-6017)
- Kendi Okuda (ORCID: https://orcid.org/0000-0002-6471-9044)
- Ping Liu (ORCID: https://orcid.org/0000-0002-8709-8965)
- Jennifer Wang (ORCID: https://orcid.org/0000-0002-2556-9100)
- Thomas Cicuto
Institutions
- University of Massachusetts Chan Medical School (US)
Publication Details
- Journal
- iScience
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1016/j.isci.2025.112501
- Citations
- 1
- Primary Topic
- Calcium signaling and nucleotide metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.12
Funders
- U.S. Department of Defense
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- Massachusetts Life Sciences Center
- National Institutes of Health
- University of Massachusetts Medical School